Park Ha Biological (NASDAQ: BYAH) wins approval for North American Amazon store

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. filed a Form 6-K to report that its North American Amazon store has been officially approved and all registration procedures are complete. This means the company can begin selling its skincare products directly to consumers through Amazon’s North American marketplace.

The company describes this step as a key milestone in its global expansion strategy, saying the Amazon onboarding process involved strict standards around brand qualifications, compliance, and market reputation. It views the approval as recognition of its brand strength, product competitiveness, and operational systems.

Park Ha plans to use Amazon as its primary international platform, relying on Fulfillment by Amazon logistics and data tools to tailor products for North American consumers and increase brand visibility. The company, founded in 2016, currently operates five directly owned stores and supports 22 franchisees in China under its “Park Ha” skincare brand.

Key Figures

Establishment year: 2016 Directly operated stores: 5 stores Franchisees: 22 franchisees

3 metrics

Establishment year 2016 Company founding year

Directly operated stores 5 stores As of October 31, 2025 in China

Franchisees 22 franchisees As of October 31, 2025 in China

Key Terms

Form 6-K, foreign private issuer, Fulfillment by Amazon (FBA), forward-looking statements

4 terms

Form 6-K regulatory

"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

foreign private issuer regulatory

"FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Fulfillment by Amazon (FBA) financial

"platform’s global traffic, Fulfillment by Amazon (FBA) overseas logistics, brand empowerment tools"

forward-looking statements regulatory

"Matters discussed in this report may constitute forward-looking statements."

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 6-K: How Foreign Companies Report to the SEC →

Available on EDGAR 07/06/2026 - 02:26 PM Accepted by SEC EDGAR 07/06/2026 - 02:25 PM

FAQ

What did Park Ha Biological (BYAH) announce in its latest Form 6-K?

Park Ha Biological announced official approval to open its North American Amazon store. All registration procedures are complete, allowing the company to sell products through Amazon as part of its global expansion strategy focused on high-end international consumer markets.

Why is the North American Amazon store important for Park Ha Biological (BYAH)?

The Amazon store is described as a critical milestone in Park Ha Biological’s global expansion strategy. The company says Amazon’s strict onboarding standards highlight its brand strength and help unlock access to global high-end consumer markets, especially in North America.

How does Park Ha Biological (BYAH) plan to use the Amazon platform?

Park Ha Biological plans to use Amazon as its primary international launching pad. It expects to leverage Amazon traffic, Fulfillment by Amazon logistics, and data tools to refine product offerings for North America and enhance long-term international brand exposure.

What business does Park Ha Biological (BYAH) operate today in China?

Park Ha Biological develops and sells skincare products under its proprietary “Park Ha” brand. As of October 31, 2025, it had five directly operated stores and 22 franchisees in China, offering products and complimentary “light beauty experience” after-sales services.

When was Park Ha Biological (BYAH) established and what is its focus?

Park Ha Biological was established in 2016 and focuses on its private skincare label. The company aims to provide cost-effective solutions for skin problems and improve confidence for women needing skin treatment through its Park Ha-branded products and services.

Does Park Ha Biological (BYAH) include forward-looking statements in this announcement?

Yes, the company states that the report and press release contain forward-looking statements. These involve risks and uncertainties, and actual results may differ materially; Park Ha Biological notes it has no obligation to update such statements except as required by law.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission File Number: 001-42453

Park Ha Biological Technology Co., Ltd.

901 & 901-2, Building C

Phase 2, Wuxi International Life Science Innovation Campus

196 Jinghui East Road

Xinwu District, Wuxi, Jiangsu Province

People’s Republic of China 214000

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Information Contained in this Form 6-K Report

Announces Official Approval of North American Amazon Store

On July 6, 2026, Park Ha Biological Technology Co., Ltd. (the “Registrant”) announced that it has successfully passed the comprehensive and rigorous process to open a store on Amazon North America. The cross-border store has been officially approved for opening, and all registration procedures are complete. This successful entry represents a critical milestone in the execution of the Registrant’s global expansion strategy, reflecting the Amazon platform’s authoritative recognition of the Registrant’s overall brand strength, core product competitiveness, and standardized operational excellence.

Amazon enforces exceptionally high standards and rigorous evaluation criteria for its onboarding process, selecting only premium enterprises with strong brand qualifications and compliance. By successfully passing this review, the Registrant has demonstrated its distinct core advantages, allowing it to stand out in a highly competitive market.

This successful launch marks the Registrant’s strategic evolution into an emerging international brand, unlocking key access channels to the global high-end consumer market. Moving forward, the Registrant will utilize Amazon as its primary international launching pad, leveraging the platform’s traffic, FBA logistics, and big data to refine its product offerings for North America, enhance brand exposure, and establish itself as a globally influential benchmark brand.

The foregoing description is qualified in its entirety by the press release attached as Exhibit 99.1 to this Form 6-K.

Issuance of Press Release

On July 6, 2026, the Registrant issued a press release announcing the event described above. A copy of the press release is attached hereto as Exhibit 99.1.

Forward Looking Statements

Matters discussed in this report may constitute forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are not historical facts. Words such as “believes,” “expects,” “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or similar expressions identify forward-looking statements. The forward-looking statements in this report are based upon various assumptions. Although the Registrant believes that these assumptions were reasonable when made, they are inherently subject to significant uncertainties and contingencies that are difficult or impossible to predict and are beyond the Registrant’s control, the Registrant cannot assure you that it will achieve or accomplish these expectations. Actual results may differ materially from those anticipated. The Registrant undertakes no obligation to update or revise any forward-looking statements, except as required by law.

EXHIBIT INDEX

The following exhibit is being filed herewith:

Exhibit No.		Description
99.1		Press release of the Company dated July 6, 2026

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Park Ha Biological Technology Co., Ltd.

Date: July 6, 2026	By:	/s/ Xiaoqiu Zhang
	Name:	Xiaoqiu Zhang
	Title:	Chief Executive Officer, Chairperson of the Board of Directors

Exhibit 99.1

Park Ha Biological Technology Co., Ltd. Announces Official Approval of Its North American Amazon Store, Launching a New Era of Brand Globalization

Wuxi, China, July 06, 2026 (GLOBE NEWSWIRE) --Park Ha Biological Technology Co., Ltd. (NASDAQ: BYAH) (“Park Ha Biological” or the “Company”) announced that it has successfully passed the comprehensive and rigorous process to open a store on Amazon North America, and the cross-border store has been officially approved for opening and all registration procedures have been completed. This successful entry represents a critical milestone in the execution of the Company’s global expansion strategy, reflecting the Amazon platform’s authoritative recognition of Park Ha Biological’s overall brand strength, core product competitiveness, and standardized operational excellence.

As the world’s leading cross-border e-commerce platform, Amazon has consistently maintained strict onboarding mechanisms with exceptionally high standards. It enforces rigorous evaluation criteria regarding brand qualifications, compliant operational frameworks, and market reputation, selecting only premium enterprises that possess core competitiveness and long-term brand-building capabilities. As such, it serves as a premier benchmark for curating high-quality brands within the global high-end consumer market. By successfully passing this multi-dimensional evaluation and securing its approval, Park Ha Biological has leveraged its differentiated core advantages to stand out in a highly commoditized market.

The successful launch on Amazon marks the formal completion of Park Ha Biological’s strategic evoluation from a “premium domestic brand” to an “emerging international brand”, fully unlocking key access channels to the global high-end consumer market.Moving forward, the Company will utilize Amazon’s store as its primary international launching pad, fully capitalizing on the platform’s global traffic, Fulfillment by Amazon (FBA) overseas logistics, brand empowerment tools, and big data resources to continuously amplify its competitive edge. On one hand, the Company will precisely iterate its product portfolio tailored to the consumption habits of core North American markets, delivering high-quality, highly adaptable, and cost-effective premium Chinese products; On the other hand, the Company will focus on refined cross-bordered brand operations to continuous enhance international brand exposure and consumer mindshare. This approach moves away from the traditional, product-only output mode of conventional foreign trade, achieving a comprehensive upgrade across technology, quality, and brand equity

With this new global starting point, Park Ha Biological will stay true to its original vision by focusing on product innovation and quality upgrades. By leveraging Amazon’s ecosystem, the Company aims to explore global market potential, compete internationally through its brand strength, and work toward becoming a benchmark domestic brand with global influence—helping more high-quality Chinese brands succeed on the global stage.

About Park Ha Biological Technology Co., Ltd.

Established in 2016, Park Ha Biological Technology Co., Ltd. is primarily engaged in developing its private skincare label, direct skincare product sales and franchise promotion under the proprietary brand “Park Ha”, with a commitment to providing cost-effective solutions to skin problems and improving the confidence of women in need of skin treatment. As of October 31, 2025, the Company has five directly operated stores and 22 franchisees in China. As part of its value-added service for the products, the Company offers “light beauty experience”, a quick complimentary after-sales beauty service performed in the directly operated stores and franchise stores. For more information, please visit the Company’s website: http://ir.parkha.cn/.

Forward-Looking Statements

Certain statements in this announcement are forward-looking statements. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs. Investors can find many (but not all) of these statements by the use of words such as “approximates,” “believes,” “hopes,” “expects, “anticipates,” “estimates,” “projects,” “intends,” “plans,” “will,” “would,” “should,” “could,” “may” or other similar expressions in this announcement. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.

For more information, please contact:

Park Ha Biological Technology Co., Ltd.
901 & 901-2, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000
ir_parkha@163.com

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document

Press Releases

EX-99.1 PRESS RELEASE OF THE COMPANY DATED JULY 6, 2026 8.6 KB